Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy
Crossref DOI link: https://doi.org/10.1186/s12935-016-0373-7
Published Online: 2017-01-05
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Dejun
Zhao, Lei
Zhou, Pengfei
Ma, Hong
Huang, Fang
Jin, Min
Dai, Xiaomeng
Zheng, Xiumei
Huang, Shaoyi
Zhang, Tao
Funding for this research was provided by:
National Natural Science Foundation of China (81172152)